The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.
Over time, clinical research has become a challenge both in terms of public health and in terms of scientific progress. Additionally, it has also become a financial challenge for institutions, especially in France where a significant part of their government funding is provided according to their ability to conduct quality clinical research. Pulmonology is a sector where clinical research is well established with strong incentives from several pharmaceutical companies and numerous academic research projects. Nevertheless, it is important to put the patient back at the centre of biomedical research. A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health. The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project. The secondary objectives are to determine: * how biomedical research is experienced / felt; * if the information delivered to the patient (orally - information note) is clearly perceived. Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.
Study Type
OBSERVATIONAL
Enrollment
500
The Questionnaire is provided in the links at the end of the declaration.
APHM - Hôpital Nord
Marseille, France
CHRU Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
The PROTOACCEPT2 questionnaire.
Time frame: day 0 (transversal study)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.